Emerging Technologies and the Law – Forms and Analysis 2017 – Research and Markets

DUBLIN, Sep 12, 2017 (BUSINESS WIRE) —
The “Commercial
Law and Intellectual Property Series: Emerging Technologies and the Law
– Forms and Analysis” book has been added to Research
and Markets’ offering.

The future has arrived ahead of schedule! Content publishers,
entertainment and media companies, communications companies, and
computer hardware and software companies are combining to create
products that are revolutionizing business and private lives. Law firms
and businesses must be prepared to react quickly or risk being left
behind.

That’s where the Emerging Technologies and the Law – Forms and
Analysis book and CD comes in. This comprehensive guide
addresses the many legal issues presented by complex cross-technology
transactions. It features 100 ready-to-use forms on CD-ROM that
eliminate guesswork and lead you through every critical step in
structuring different kinds of agreements.

You’ll find clear explanations of:

  • The technological and legal issues involved
  • An overview of patent law as it applies to emerging technologies
  • Checklists of important factors to consider before beginning a complex
    cross-technology transaction
  • And more!

For more information about this book visit https://www.researchandmarkets.com/research/9zpk58/commercial_law

View source version on businesswire.com: http://www.businesswire.com/news/home/20170912006440/en/

SOURCE: Research and Markets

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related
Topics: Legal,
Intellectual
Property

Copyright Business Wire 2017

Go to Source

The Remaking Of Wall Street: Paper Examines How Private Equity Firms Mirror Investment Banks In Power And Influence, By Neil Schoenherr September 12, 2017

Private equity firms are more financially stable and pose less systemic risk to the global economy than the large investment banks that went defunct during the financial crisis of 2007-09, finds a new analysis by a financial regulation expert at Washington University in St. Louis School of Law.

Tuch

“Private equity firms are structured and funded in ways that may address the basic shortcoming that led to investment banks’ downfall — specifically, the use of short-term debt to fund longer-duration assets,” said Andrew Tuch, professor of law and author of “The Remaking of Wall Street,” forthcoming in the Harvard Business Law Review.

Tuch argues that, in the face of onerous post-crisis reforms, Wall Street has evolved to displace investment banks with more financially resilient institutions.

“Importantly, however, ongoing changes in private equity firms’ broker-dealer activities raise systemic concerns that require active regulatory monitoring,” Tuch said. “There are systemic and financial stability concerns arising from the funds that these firms manage, particularly their hedge and credit funds, about which little detailed information is publicly available.”

Reforms proposed under the Trump Administration to soften bank holding company regulation will affect the competitive environment for private equity firms with uncertain effect, Tuch said.

Could they grow to become a problem similar to the investment banks in the collapse 10 years ago?

“What is clear is that as private equity firms continue to evolve, and especially if their broker-dealer activities grow further, the parallels with the former investment banks will suggest greater danger and therefore demand a more robust regulatory response,” he said.

Go to Source

Firms releasing data with name to face strict action

New Delhi  : Law and IT minister Ravi Shankar Prasad Tuesday warned companies of consequences if they release data or information about an individual with name and without his or her consent. “Some things are completely private, should not come in public. Today, I would like to gently remind, all the companies dealing with data, that if any data of an individual is released by name you will suffer consequence unless there is specific consent of person whose data you are seeking to make public,” Prasad said while launching a nation-wide hackathon.

   He said the government is committed to make best use of big data in establishing rule of precision governance. “While doing so every care would be taken to ensure that strict privacy rights of individuals are protected. However, unauthorised use of data would be dealt with iron-hand to ensure that nothing comes in the way of making data-analytics a national movement,” he said.

 The government has launched open data platform in 2012 for public use. Later, it issued an open licence for people. The minister said the government has opened up many data sets for developing innovating solutions but the data has anonymity.      “Please don’t confuse. Government data is anonymous. It does have an identity. If data is anonymous. It is free from all the constraints. It should be available for innovation,” Prasad said.

     He said the Supreme Court in its recent judgement has given elaborate consideration the way India is innovating, embarked on digital empowerment with financial inclusion.The minister said that the apex court has said that right to privacy is not absolute. “If an individual data which is private is disclosed without his consent surely consequences will follow and should follow. I want to assure that strict privacy rights of an individual must be protected. We in the government will ensure that it is protected,” Prasad said.

   He said the government will be very tough in any unauthorised use of data in the interest of India’s citizen for their right of privacy but in the garb of privacy it should not be hyped that innovation, initiative, entrepreneurship development is restrained. “We have to find middle path. On middle path, I have always said that data availability, data utility, data anonymity, data privacy — on these four principle if we proceed then surely India will emerge as a very important place as a democracy ruled by law, as a  beacon for the world as to how India has set up a robust regime for data utilisation maturity,” Prasad said.

© Copyright Indian National Press (Bombay) Private Limited 2017. All Rights Reserved.

Go to Source

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in IntelliPharmaCeutics International Inc. of Class Action Lawsuit and Upcoming Deadline – IPC

NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against IntelliPharmaCeutics International Inc. (“IntelliPharma” or the “Company”) (NASDAQ: IPCI) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-06045, is on behalf of a class consisting of investors who purchased or otherwise acquired IntelliPharma securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased IntelliPharma securities between January 14, 2016, and July 26, 2017, both dates inclusive, you have until September 29, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

IntelliPharma is a pharmaceutical company specializing in research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s main product candidate is Rexista, an abuse-deterrent oxycodone hydrochloride extended release tablets. Rexista is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) IntelliPharma failed to conduct a human abuse liability study to support its Rexista New Drug Application (“NDA”); (ii) the Company did not include abuse-deterrent studies conducted to support abuse-deterrent label claims related to abuse of the drug by various pathways, including oral, intra-nasal and intravenous routes of abuse; (iii) IntelliPharma was not submitting sufficient data to support approval of the Rexista NDA; and (iv) as a result of the foregoing, IntelliPharma’s public statements were materially false and misleading at all relevant times.

On July 27, 2017, before the market opened, IntelliPharma issued a press release announcing an update on the U.S. Food and Drug Administration (“FDA”) Advisory Committee Meeting for Rexista (“July 2017 Press Release”). The press release stated, in relevant part, that the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee “voted 22 to 1 in finding that the Company’s [NDA] for Rexista abuse-deterrent oxycodone hydrochloride extended release tablets should not be approved at this time. The committees also voted 19 to 4 that the Company has not demonstrated that Rexista has properties that can be expected to deter abuse by the intravenous route of administration, and 23 to 0 that there are not sufficient data for Rexista to support inclusion of language regarding abuse-deterrent properties in the product label for the intravenous route of administration.”

On this news, IntelliPharma’s share price fell $1.13, or 45.38%, to close at $1.36 on July 27, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP

ReleaseID: 475247

NEW YORK, NY / ACCESSWIRE / September 12, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against IntelliPharmaCeutics International Inc. (“IntelliPharma” or the “Company”) (NASDAQ: IPCI) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-06045, is on behalf of a class consisting of investors who purchased or otherwise acquired IntelliPharma securities, seeking to recover compensable damages caused by defendants’ violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased IntelliPharma securities between January 14, 2016, and July 26, 2017, both dates inclusive, you have until September 29, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

IntelliPharma is a pharmaceutical company specializing in research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s main product candidate is Rexista, an abuse-deterrent oxycodone hydrochloride extended release tablets. Rexista is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) IntelliPharma failed to conduct a human abuse liability study to support its Rexista New Drug Application (“NDA”); (ii) the Company did not include abuse-deterrent studies conducted to support abuse-deterrent label claims related to abuse of the drug by various pathways, including oral, intra-nasal and intravenous routes of abuse; (iii) IntelliPharma was not submitting sufficient data to support approval of the Rexista NDA; and (iv) as a result of the foregoing, IntelliPharma’s public statements were materially false and misleading at all relevant times.

On July 27, 2017, before the market opened, IntelliPharma issued a press release announcing an update on the U.S. Food and Drug Administration (“FDA”) Advisory Committee Meeting for Rexista (“July 2017 Press Release”). The press release stated, in relevant part, that the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee “voted 22 to 1 in finding that the Company’s [NDA] for Rexista abuse-deterrent oxycodone hydrochloride extended release tablets should not be approved at this time. The committees also voted 19 to 4 that the Company has not demonstrated that Rexista has properties that can be expected to deter abuse by the intravenous route of administration, and 23 to 0 that there are not sufficient data for Rexista to support inclusion of language regarding abuse-deterrent properties in the product label for the intravenous route of administration.”

On this news, IntelliPharma’s share price fell $1.13, or 45.38%, to close at $1.36 on July 27, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

SOURCE: Pomerantz LLP

ReleaseID: 475247

Source URL: https://marketersmedia.com/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-intellipharmaceutics-international-inc-of-class-action-lawsuit-and-upcoming-deadline-ipc/238680

Source: AccessWire

Release ID: 238680

Go to Source

NSA Grants $2.4 Billion Tech Contract As Surveillance Law Faces Challenges

As the United States Congress sets to review one of the most controversial surveillance laws on the country’s books, the National Security Agency (NSA) quietly began handing out a massive contract for a secretive program.

Director of National Intelligence Dan Coats and Attorney General Jeff Sessions formally asked Congress Monday to reauthorize Title VII of the Foreign Intelligence Surveillance Act (FISA) in order to allow current surveillance programs to continue operations.

At the heart of the issue is a key law, Section 702, that grants the NSA the ability to tap the communications of foreigners located overseas. The spying initiative is ostensibly for intelligence and security purposes and intelligence officials claim it is crucial to preventing terrorist attacks.

STRUCTURE SECURITY -- USE THIS ONE Newsweek is hosting a Structure Security Event in San Francisco, Sept. 26-27. Photo: Newsweek Media Group

Section 702 was passed in 2008 in order to give intelligence agencies within the U.S. the ability to legally gather intelligence and conduct surveillance on non-citizens living overseas but communicating on the networks of U.S. telecommunications companies.

The law will not gain reauthorization without some protest that may prove enough to strike down the primary provision, given the growing amount of criticism it has faced in recent years.

One of the leading voices of dissent on Section 702 has come from Senator Ron Wyden, D-Or. A member of the Senate Intelligence Committee, Wyden believes the NSA has used the law to collect incidental data on millions of Americans who are in no way related to targets of the NSA.

“How many innocent law-abiding Americans have been swept up in this program that has been written and developed to target foreigners overseas?” he wrote in a statement earlier this year. “Congress’s judgment about the impact of section 702 depends on getting this number.”

While Wyden and his colleagues debate the merits of the surveillance law, the NSA has quietly launched a massive new initiative that will reportedly hand out more than $2.4 billion to technology firms over the next decade, NextGov reported.

The first chunk of the massive, three-part contract was granted to CSRA, an information technology services company that works with government agencies on a number of projects but is most heavily involved in national security ventures.

CSRA will begin work on a classified NSA program known as Groundbreaker. The details on the program are few for the time being, though it appears it can be traced back as far as 2001 and is likely an effort to outsource the NSA’s IT operations.

At the time, then-NSA director Michael Hayden said the program would allow NSA to “refocus assets on the agency’s core missions of providing foreign signals intelligence and protecting U.S. national security-related information systems by turning over several information technology infrastructure services for industry’s purview.”

It is unclear how, if at all, the Groundbreaker program would be affected by the pending reauthorization of Section 702. The program will likely continue regardless of the outcome of the Congressional debate over the law.

Go to Source

Law firm that represents big media clients in 1st amendment cases merges with Ballard Spahr

Ballard Spahr and Levine Sullivan Koch & Schulz, a well-known First Amendment and media law boutique —announced a merger, effective October 1.

The firm, which will retain the name Ballard Spahr, brings together two media law practices.

All 25 of LSKS’s lawyers, – including its four named partner Lee Levine, Michael D. Sullivan, Elizabeth C. Koch, and David A. Schulz – will join Ballard Spahr in its Washington, D.C., New York, Philadelphia, and Denver offices.

Ballard Spahr operates an office in Wilmington

Advertisement

Its lawyers, including Levine – who has been described inChambers USAas “the greatest First Amendment attorney in the United States” – have argued landmark cases before the U.S. Supreme Court and in state and federal courts across the country.

“We have made one outstanding addition after another to our Media and Entertainment Law Group – including Practice Leaders David Bodney and Chuck Tobin, who are recognized as among the very best in the business, ” said Ballard Spahr Chair Mark Stewart. “With the arrival of LSKS, we will have one of the largest practices of its kind in the country. The LSKS lawyers are terrific people whose dedication to this critically important work mirrors ours. It is an exciting development for both firms.”

Media attorneys at Ballard Spahr and LSKS represent and counsel clients across platforms and industry sectors—news, entertainment, sports, publishing, advertising, and advocacy.

The attorneys defend media clients in defamation, privacy, and First Amendment litigation; prosecute actions to secure open government and public access; defend journalists against civil, criminal, and grand jury subpoenas; advise reporters in their news gathering; provide pre-publication and pre-broadcast counseling to a wide array of media; and help clients protect their intellectual property rights.

LSKS has been at the vanguard in representing the media in many of the most significant and consequential First Amendment cases in recent years.

Last month, the firm achieved dismissal in federal court of a defamation suit brought againstThe New York Timesby former vice presidential candidate Sarah Palin.

LSKS also helped the Associated Press obtain the release of sealed documents in the Bill Cosby sexual assault cases; successfully defended NBCUniversal in a defamation suit brought by George Zimmerman, the man acquitted in the fatal shooting of Trayvon Martin; and succeeded in reversing a jury verdict against the estate of famed Navy SEAL Chris Kyle in a case brought by Jesse Ventura following the publication of Kyle’s best-selling bookAmerican Sniper: The Autobiography of the Most Lethal Sniper in U.S. Military History.

The affiliation also comes at a time of increased tensions between the media and Trump Administration. Such tensions have been a part of any presidency. However, there have been fears that the administration’s actions could undermine the key amendment to the Constitution.

Another growing area is online media and the issues raised by social media, blogging and other forms of expression. There is also the controversial issue of “fake news” and allegations of Russian interference through media sites that spread false or inflammatory posts.

The LSKS merger is the second to be announced by Ballard Spahr. Last week, Ballard Spahr announced that it will join with Lindquist & Vennum—a Minneapolis-based law firm known as a leader in middle-market M&A and private equity deal-making—effective January 1, 2018.

Ballard Spahr LLP has more than 500 lawyers in 13 offices in the United States. For more information, please visitwww.ballardspahr.com.

Advertisement

Go to Source

Report could mean big firms pay more tax

Multinationals will end up paying more tax if recommendations in a high-level review of Ireland’s tax regime are adopted, according to the head of tax at Chartered Accountants Ireland.

Director Brian Keegan said specific proposals in the review by economist Seamus Coffey for the Department of Finance on capital allowances for companies holding intellectual property in Ireland could lead to multinationals paying more tax.

Other recommendations in the report that touch on transfer pricing between companies could affect both foreign and Irish-owned companies by adding to the burden of paper work, said Mr Keegan.

Finance Minister Paschal Donohoe said he welcomed Mr Coffey’s findings that increases in corporation tax revenues were sustainable through 2020. Describing the report as a “technical document”, he said he would consult widely on the recommendations.

The report was commissioned by his predecessor, Michael Noonan, following the Government’s decision to appeal the EU ruling that Apple repay the State €13bn in back taxes.

The 140-page report contains 18 recommendations, including measures to ensure the tax code does not favour individual taxpayers, as well as proposals for increased tax transparency.

On the report, Children’s Minister Katherine Zappone said that “Ireland has taken concrete steps towards a better, fairer, and more transparent tax system”.

The report was also commissioned following a period when multinationals faced scrutiny for their global tax affairs and Ireland’s tax regime and accounting arrangements, such as the “double Irish”, generated hostile media coverage across the world.

An initiative driven by the Organisation for Economic Co-operation and Development subsequently led to multinationals rearranging their global tax affairs.

Multinationals transferred huge levels of intellectual property into Ireland, which helped increase the corporate tax base by billions of euro.

The jibe of “leprechaun economics” by a leading international economist came after the transfers artificially boosted the output of the Irish economy as measured by GDP.

The report recommends international transfer guidelines should be passed into Irish law and extended to non-trading income.

The rules could be applied to SMEs but only after taking into account the “administrative burden” on small firms.

It also calls for “an adequately resourced” body to “ensure that Ireland protects its corporation tax base”.

Chartered Accountants said: “The Coffey report into corporation tax policy in Ireland was born of political necessity, but Government should be careful to use its recommendations to modernise the system, rather than as a justification to levy new taxes on business.”

Ibec said the effects on SMEs must be carefully considered.

Fianna Fáil finance spokesman Michael McGrath said Ireland’s tax regime must remain competitive. “In addition to this, we must make sure it is sustainable in terms of our tax revenues and we must continue the progress made on tax transparency.”

Christian Aid said Ireland’s rules on intellectual property “in recent years has become a spectacular source of tax avoidance for multinational companies”.

Go to Source

Centre disqualifies 1 lakh directors of shell firms

The ministry has identified 1,06,578 directors for disqualification under Section 164(2)(a) of the Companies Act, 2013 as on September 12, 2017.

New Delhi: As part of crackdown on shell companies, corporate affairs ministry has disqualified  over 1 lakh directors as companies under them failed to submit financial statement for three years. 

Corporate affairs ministry has already cancelled registration of around 2.10 lakh defaulting companies and the finance ministry had asked banks to restrict their bank operations. 

The ministry has identified 1,06,578 directors for disqualification under Section 164(2)(a) of the Companies Act, 2013 as on September 12, 2017.

As per section 164 of the Companies Act, 2013, any person who is or has been a director in a company which has not filed financial statements for any continuous period of three financial years will not be eligible for re-appointment as a director in that company or appointed in other company for a period of five years. 

“It may be noted that prior to action against defaulting companies, there were about 13 lakh companies in the Registry. However, after closing of around 2.10 lakh companies, there are about 11 lakh companies having active status,” the corporate affairs ministry said. 

Minister of state for corporate affairs P.P. Chaudhary said all the concerned agencies are handling this issue on priority. “The present government has vowed to fight blackmoney and fighting the menace of shell companies is an imperative element of such fight. The fight against blackmoney shall be incomplete without breaking the network of shell companies. Possibility of using the shell companies for laundering the black money cannot be undermined,” said Mr Chaudhary. 

He said that  disqualification under Section 164 of the act is by operation of law. “We are identifying the defaulting directors of these shell companies. My officers have assured me that by the end of this month, we would be ready with the relevant details of all defaulting directors of these shell companies,” he added.  The ministry said it is further analysing the data of these de-registered companies  to identify the directors and the significant beneficial interests behind these companies. 

Go to Source

Time to lure cryptocurrency firms to Malta – BitMalta

Companies involved in cryptocurrency should be incentivised to move to the island, according to a virtual currency advocacy group.

BitMalta, a group of professionals raising awareness on the technology, has submitted a list of proposals to Gaming Parliamentary Secretary Silvio Schembri to facilitate its success in Malta.

One such proposal is to introduce tax incentives or subsidies for professionals working in the sector.

Cryptocurrencies are digital currencies which rely on an encryption system known as Blockchain to oversee transactions independent of a central bank – the most popular of which is Bitcoin.

Malta prepares for blockchain

Earlier this year, Prime Minister Joseph Muscat announced that Malta would be leading the race to embrace the payment system and set the standards for other countries to follow. Many raised concerns, however, including the Malta Financial Service Authority, which warned the currency was not a regulated digital instrument.

“Unlike traditional money, acceptance of payment in virtual currency depends entirely on the voluntary consent of the recipient. Furthermore, providers of services in relation to virtual currencies are currently neither regulated by law nor authorised by the MFSA,” the authority said.

In its proposals, BitMalta said the incentives could include widening the scope of the tax schemes for finance and gambling professionals to Blockchain coders and other Blockchain-oriented professionals.

The group also believes the government should urge financial and credit institutions to keep up a dialogue with Blockchain-related companies wishing to open a bank account on the island.

This, they said, would facilitate the process, subject to sufficient safeguards.

Other proposals include the issuance of monthly Blockchain updates in the form of a newsletter “to keep the momentum going”.

Maltese delegates should also be sent to prominent international Blockchain conferences to keep Malta at the forefront, the BitMalta proposals say.

Two months ago, the Times of Malta reported how Malta’s first Bitcoin ATM had been set up.

The machine, which has been installed outside a Sliema shop on Blanche Huber Street, allows users to buy Bitcoin and check their e-wallet balance using QR codes displayed on their smartphone.

The MFSA reacted to the news, warning the public that they were not protected when using virtual currencies as a means of payment.

BitMalta’s proposals also called for a set of guidelines to be published for anyone considering installing such an ATM and potential vetting to be considered.

Go to Source

City law firms boosted by growth as they weather Brexit uncertainty

Law firms in the City have weathered tough economic and political conditions to post growth overtaking that of regional firms, according to national audit, tax and advisory firm Crowe Clark Whitehill.

The company’s annual law firm benchmarking report found that 92 per cent of City law firms experienced growth this year, up 27 per cent on 2016. The number of companies reporting a fall in revenue had also dropped from 23 per cent last year to eight per cent.

Read more: City lawyers warn a Brexit would make red tape worse

Regional law firms had a more difficult period though. While 80 per cent reported growth in 2017, only 28 per cent said revenues had increased by more than 10 per cent, compared to a third of firms in 2016, and over half in 2015.

Many firms were successful at converting turnover growth into profit, with profit per equity partner rising for 60 per cent of companies, including nearly 70 per cent of City firms.

Steve Gale, partner in Crowe’s London office, said: “The ability of firms to convert turnover growth into profit has been encouraging. Overall, City firms have had a better year than in 2016, with only eight per cent reporting a fall in revenue compared to 23 per cent last year.”

City firms cited Brexit, government policy and the regulatory environment as their main concerns going forward. Nearly half of the companies anticipated Brexit as a net threat, though just under half of regional firms said they felt Brexit will have little impact on them.

Louis Baker, head of professional practices at Crowe, said:

City firms are understandably worried about the continuing political and economic uncertainty, with a quarter of City firms viewing Brexit as the biggest challenge to their future success, and nearly half citing it as a ‘net threat’.

Grappling with fierce price competition – including the threat of new market entrants, particularly the encroachment of other professional services firms into legal services – is also a key worry for City lawyers, while regional firms are more concerned about the talent pool, harbouring fears over the availability of high quality personnel.

Despite staffing concerns, average headcount did continue to rise, for both City and regional firms, with the City out ahead, posting a 7.5 per cent rise in fee earner numbers.

Read more: Ranked: City law firms with staff fleeing to Ireland after Brexit

Go to Source